Moneycontrol PRO
HomeNewsTrendsCovaxin Phase-3 trial: COVID vaccine volunteer's death due to poisoning, says Bharat Biotech

Covaxin Phase-3 trial: COVID vaccine volunteer's death due to poisoning, says Bharat Biotech

The volunteer received the trial vaccine at Bhopal's People's Medical College on December 12, 2020. He was found dead nine days later at his home.

January 10, 2021 / 07:35 IST
Covaxin, Bharat Biotech

Bharat Biotech International Limited in a statement issued on January 9 said the probable cause of death of a volunteer during the Phase-III trials of its COVID-19 vaccine in Madhya Pradesh was cardio-respiratory failure as a result of suspected poisoning. The company added that the case is under police investigation and the death is not related to the vaccine trial.

A volunteer named Deepak Maravi received the trial vaccine at Bhopal's People's Medical College on December 12, 2020. He was found dead nine days later at his home. The investigation into the cause of death is still going on.

“We would like to state that a volunteer passed away on December 21, 2020, and the death was reported to the People’s College of Medical Sciences and Research Centre by the son of the deceased. The volunteer, at the time of enrolment, had fulfilled all the inclusion and exclusion criteria to be accepted as a participant in the Phase-III trial and was reported to be healthy in all the site follow-up calls post seven days of his dosing and no adverse events were observed or reported. The volunteer passed away nine days after the dosing and preliminary reviews by the site indicate that the death is unrelated to the study dosing,” the company said in its statement.

Meanwhile, Madhya Pradesh Health Minister Prabhuram Choudhary on January 9 said that the postmortem report is awaited.

"We conduct the vaccine trials only according to the guidelines issued by the Indian Council of Medical Research. A person shows the side effects within 30 minutes after getting the vaccine. Its effect remains visible for the next 24 to 48 hours. However, the volunteer died many days after he was administered the vaccine," he said as questions were being raised on the safety of the COVID vaccines that have been approved for emergency use.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"It is very unfortunate that the person died, but the initial reports show that his death occurred due to poisoning. The post-mortem report is still awaited. We can say anything only after the final report comes," he added.

With inputs from ANI
Moneycontrol News
first published: Jan 9, 2021 07:40 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347